Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entero Therapeutics Inc
ENTO
Healthcare
Biotechnology
Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of...
celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for multiple GI conditions, including gastroparesis, and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. The Company also intends to develop Niclosamide, an oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, and immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 1:20pm
FWBI ...Sure does seem strange how this can churn 11.7 mil..
shares and be down 3 cents.... I mean holy cr*p.....there was only 1.4 million shares p/s post RS then they printed some cheap paper via a P.O...that was 3.4 million shares at $1.75...so all totaled
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 11:55am
FWBI .... This is the way I feel
https://www.youtube.com/watch?v=Q4cb0Wha1TI
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 11:31am
FWBI ..... And u thought I just talking "Smack"
LOts of Volume.....but Price action is heading South....go figure "skating" Keep up the good work Mr. Maggot !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 10:05am
FWBI ..... What did I tell everyone in my last post?
It's pretty obvious what Mr. M is doing Just hang in there....keep your powder dry.....I'd say this could go quite a bit lower But I will be there like "Joe the Bear" with lard in
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 9:11am
FWBI..... Hard to say but...This doesn't look like....
"Prime Time" to me Paytience..... The Best is yet to come !!!! JMHO.... Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 31, 2022 7:53am
FWBI..... Good morning Early a.m runner on NR ; )
07:37 AM EDT, 10/31/2022 (MT Newswires) -- First Wave BioPharma (FWBI) shares were up 23% premarket Monday after saying it engaged Rho to manage its phase 2 clinical trial for the evaluation of
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 31, 2022 7:00am
New Press Release - First Wave BioPharma Engages Rho to Manage Phase 2 Clinical Trial of Enhanced Adrulipase Formulation
Phase 2 clinical trial investigating adrulipase as a treatment for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis expected to initiate prior to year-end 2022 BOCA RATON, Fla., Oct. 31, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (...
read article.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 28, 2022 3:59pm
FWBI .... Nice close
LMFAO
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 28, 2022 12:14pm
FWBI ..... Come on Mr. M
Isn't this "Fryday"......still waiting for the next shoe to drop Do us all a big favor.... Need some more cheap paper ; ) Have a great weekend !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 27, 2022 3:59pm
FWBI ..... Bwaaahhhaahahahah
Mr. M is f'king hilarious Lower Pal !!!!
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 27, 2022 1:31pm
FWBI ..... all "sideways action" ...ever since Mr. M....
Did the "Rig Pull" on 10/25/22...... Come on Mr. M....you can do better than that ; ) Still waiting Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 26, 2022 4:01pm
FWBI ..... U gotta shake it harder than that Mr. M
Cheap paper makes the world go around !! C u 2morrow !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 26, 2022 3:30pm
FWBI ..... Mr. M....ur a pro !
R u havin fun? LMFAO
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 26, 2022 1:24pm
FWBI .....when the stirrings done.....
Can I lick the spoon
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 26, 2022 9:24am
FWBI ..... LMFAO ....last 15 mins of trading yesterday
Big volume down in the 5 min candle.....then bigger volume picking up all the maniped shares $1.30 this a.m Stick & Stay I always say ; ) Cheers !
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth